. Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Liestal, Switzerland, January 26, 2018 – Santhera Pharmaceuticals (SIX: SANN) announces that the Committee for Medicinal … Read more

Read More

“This should be especially applied for premature or newborn babies or children with an underlying disease,” Prof. Dr. Christoph Berger says, co-Head of Infectious Diseases and Head of Hospital Hygiene at Zurich Children’s Hospital. Since frequent … Read more

Read More